What is it about?

Gender differences are seen in many disease processes. There is a growing awareness for gender-specific hormonal regulation of immunomodulatory roles however,the mechanism remains unexplained. 2-Methoxyestradiol (2ME2) is an endogenous metabolite of estrogen that is non-estrogenic and is found in lower levels in men than women.2ME2 has been studied in cancer as an antimitotic-agent that is beneficial by its selectivity in targeting only actively proliferating cancer cells without toxicity to normal cells. As its effect in a transplant rejection setting remains unknown, we hypothesized that 2ME2 can inhibit activated T-cell function.

Featured Image

Why is it important?

Gender differences are seen in many disease processes. There is a growing awareness for gender-specific hormonal regulation of immunomodulatory roles however,the mechanism remains unexplained. 2-Methoxyestradiol (2ME2) is an endogenous metabolite of estrogen that is non-estrogenic and is found in lower levels in men than women.2ME2 has been studied in cancer as an antimitotic-agent that is beneficial by its selectivity in targeting only actively proliferating cancer cells without toxicity to normal cells. As its effect in a transplant rejection setting remains unknown, we hypothesized that 2ME2 can inhibit activated T-cell function.

Read the Original

This page is a summary of: GENDER SPECIFIC INFLUENCES ON EFFECTOR T-CELL FUNCTION AND PROLIFERATION: 2-METHOXYESTRADIOL MODULATES CELLULAR REJECTION, Canadian Journal of Cardiology, October 2014, Elsevier,
DOI: 10.1016/j.cjca.2014.07.434.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page